论文部分内容阅读
Therapeutic agents used to treat glaucoma are designed to decrease the intra-ocular pressure (IOP) either by decreasing the aqueous humor production in the ciliary body and/or by enhancing the aqueous humor drainage from the eye. Oral carbonic an-hydrase inhibitors (CAIs) were the mainstay in the glaucoma therapy but of late, these agents have become less popular due to
Therapeutic agents used to treat glaucoma are designed to reduce the intra-ocular pressure (IOP) either by decreasing the aqueous humor production in the ciliary body and / or by enhancing the aqueous humor drainage from the eye. Oral carbonic an-hydrase inhibitors (CAIs ) the the mainstay in the glaucoma therapy but of late, these agents have become less popular due to